Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
GMAB
Stock Latest News
The Fly
Genmab price target lowered to DKK 1,500 from DKK 1,700 at JPMorgan
15h ago
GMAB
Premium
The Fly
Genmab reports ‘encouraging anti-tumor activity’ for Rina-S in Phase 1/2 trial
5d ago
GMAB
Premium
Company Announcements
Genmab Continues Share Buy-back Program Amid Strategic Financial Management
5d ago
6K
GMAB
Premium
The Fly
Genmab price target lowered to DKK 2,000 from DKK 2,300 at RBC Capital
9d ago
GMAB
Premium
Company Announcements
Genmab Executes Share Buy-back Transactions in May 2025
11d ago
6K
GMAB
Premium
Ratings
Genmab’s Promising Rina-S Developments Drive Buy Rating Amid Strong Initial Study Results
11d ago
GMAB
Premium
Ratings
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment
15d ago
GMAB
Premium
Company Announcements
Genmab A/S Updates Articles to Enhance Capital Flexibility
17d ago
6K
GMAB
Premium
Company Announcements
Genmab Announces Capital Increase Following Employee Warrant Exercise
18d ago
6K
GMAB
Premium
The Fly
Bolt Biotherapeutics initiated with a Buy at Lake Street
18d ago
BOLT
GMAB
Premium
Ratings
Genmab’s Strategic Forecast and Pipeline Potential Drive Buy Rating
18d ago
GMAB
Premium
Company Announcements
Genmab Executes Share Buy-back Transactions in May 2025
19d ago
6K
GMAB
Premium
The Fly
Genmab price target lowered to $35 from $37 at H.C. Wainwright
24d ago
GMAB
Premium
Company Announcements
Genmab Executes Share Buy-back Transactions in May 2025
26d ago
6K
GMAB
Premium
Ratings
Genmab’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
26d ago
GMAB
Premium
Ratings
Genmab’s Strong Performance Overshadowed by Patent Expiration Concerns and Competitive Challenges
29d ago
GMAB
Premium
The Fly
Genmab upgraded to Buy from Hold at Nordea
29d ago
GMAB
Premium
Company Announcements
Genmab Reports Strong Q1 2025 Earnings Growth
29d ago
GMAB
Premium
Company Announcements
Genmab Reports Strong Q1 2025 Financial Results and Product Approvals
30d ago
6K
GMAB
Premium
The Fly
Genmab reports Q1 revenue $715M vs. $603M last year
30d ago
GMAB
Premium
The Fly
Genmab reaffirms FY25 guidance
30d ago
GMAB
Premium
Company Announcements
Genmab Executes Share Buy-back Transactions in Early May 2025
1M ago
6K
GMAB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.